A Study on Serum Leptin Levels and Lipid Profile in Patients with Stable Coronary Artery Disease (CAD)

A Study on Serum Leptin Levels and Lipid Profile in Patients with Stable Coronary Artery Disease (CAD)

Cardiovascular diseases (CVD) are a group of disorders involving the heart and its related blood vessels. Cardiovascular diseases CVD is now a common cause of global mortality and largely contributed to the disease-related disabilities which poses a major impact on the costs of treatment and healt...

Full description

Saved in:
Bibliographic Details
Main Author: Ibrahim, Bujang
Format: Thesis
Language:English
Published: 2021
Subjects:
QD Chemistry
R Medicine (General)
Online Access:http://ir.unimas.my/id/eprint/36751/1/Ibrahim.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-unimas-ir.36751
record_format uketd_dc
institution Universiti Malaysia Sarawak
collection UNIMAS Institutional Repository
language English
topic QD Chemistry
R Medicine (General)
spellingShingle QD Chemistry
R Medicine (General)
Ibrahim, Bujang
A Study on Serum Leptin Levels and Lipid Profile in Patients with Stable Coronary Artery Disease (CAD)
description Cardiovascular diseases (CVD) are a group of disorders involving the heart and its related blood vessels. Cardiovascular diseases CVD is now a common cause of global mortality and largely contributed to the disease-related disabilities which poses a major impact on the costs of treatment and healthcare in most countries. Since the last decade, cardiovascular diseases have accounted for 31% of deaths worldwide and the single largest contributor to the global mortality. Leptin, has been shown to play important role in the development of cardiovascular diseases. However, the association of leptin and the long term outcomes of CVD patients is rarely being reported. This research aimed to determine the serum leptin levels and lipid profiles among patients with stable coronary artery disease. In this study, 100 participants were recruited from the pool of patients attending the Cardiac Clinic at the Sarawak Heart Centre (PJS) from the year 2015 till 2016. The serum leptin levels were determined by using ELISA method, whereas the lipid profile level were determined by using the blood biochemistry analyser Beckman Coulter AU680. Results showed a positive correlation between lipid profile parameter and serum leptin levels in patients with stable coronary artery disease (CAD). However only one parameter of the lipid profile, which is the triglyceride level shows positive correlation with correlation coefficient, r:0.318 and p value <0.005. The strength of linear relationship increased in the correlation of serum leptin level and triglyceride level among the non-diabetic stable CAD patients (r = 0.439, p <0.001). Serum leptin levels correlate well with the body mass index of the stable CAD patients involved in the study (<0.001). Positive correlation between serum leptin levels and BMI also seen among non-diabetic groups (<0.001). Based on these findings, a combo test including drugs lower lipid levels and drugs lower leptin level might potentially useful to treat and manage coronary artery disease patients. Therefore, a future study is required to test this intervention and hopefully this can bring a new insights regarding the role of these biomarkers in cardiovascular disease research, testing and its clinical management.
format Thesis
qualification_level Master's degree
author Ibrahim, Bujang
author_facet Ibrahim, Bujang
author_sort Ibrahim, Bujang
title A Study on Serum Leptin Levels and Lipid Profile in Patients with Stable Coronary Artery Disease (CAD)
title_short A Study on Serum Leptin Levels and Lipid Profile in Patients with Stable Coronary Artery Disease (CAD)
title_full A Study on Serum Leptin Levels and Lipid Profile in Patients with Stable Coronary Artery Disease (CAD)
title_fullStr A Study on Serum Leptin Levels and Lipid Profile in Patients with Stable Coronary Artery Disease (CAD)
title_full_unstemmed A Study on Serum Leptin Levels and Lipid Profile in Patients with Stable Coronary Artery Disease (CAD)
title_sort study on serum leptin levels and lipid profile in patients with stable coronary artery disease (cad)
granting_institution Universiti Malaysia Sarawak
granting_department Faculty of Medicine and Health Science
publishDate 2021
url http://ir.unimas.my/id/eprint/36751/1/Ibrahim.pdf
_version_ 1783728480358236160
spelling my-unimas-ir.367512023-05-10T03:45:17Z A Study on Serum Leptin Levels and Lipid Profile in Patients with Stable Coronary Artery Disease (CAD) 2021 Ibrahim, Bujang QD Chemistry R Medicine (General) Cardiovascular diseases (CVD) are a group of disorders involving the heart and its related blood vessels. Cardiovascular diseases CVD is now a common cause of global mortality and largely contributed to the disease-related disabilities which poses a major impact on the costs of treatment and healthcare in most countries. Since the last decade, cardiovascular diseases have accounted for 31% of deaths worldwide and the single largest contributor to the global mortality. Leptin, has been shown to play important role in the development of cardiovascular diseases. However, the association of leptin and the long term outcomes of CVD patients is rarely being reported. This research aimed to determine the serum leptin levels and lipid profiles among patients with stable coronary artery disease. In this study, 100 participants were recruited from the pool of patients attending the Cardiac Clinic at the Sarawak Heart Centre (PJS) from the year 2015 till 2016. The serum leptin levels were determined by using ELISA method, whereas the lipid profile level were determined by using the blood biochemistry analyser Beckman Coulter AU680. Results showed a positive correlation between lipid profile parameter and serum leptin levels in patients with stable coronary artery disease (CAD). However only one parameter of the lipid profile, which is the triglyceride level shows positive correlation with correlation coefficient, r:0.318 and p value <0.005. The strength of linear relationship increased in the correlation of serum leptin level and triglyceride level among the non-diabetic stable CAD patients (r = 0.439, p <0.001). Serum leptin levels correlate well with the body mass index of the stable CAD patients involved in the study (<0.001). Positive correlation between serum leptin levels and BMI also seen among non-diabetic groups (<0.001). Based on these findings, a combo test including drugs lower lipid levels and drugs lower leptin level might potentially useful to treat and manage coronary artery disease patients. Therefore, a future study is required to test this intervention and hopefully this can bring a new insights regarding the role of these biomarkers in cardiovascular disease research, testing and its clinical management. Universiti Malaysia Sarawak 2021 Thesis http://ir.unimas.my/id/eprint/36751/ http://ir.unimas.my/id/eprint/36751/1/Ibrahim.pdf text en validuser masters Universiti Malaysia Sarawak Faculty of Medicine and Health Science Research Acculturation Grant Scheme (RAGS), Ministry of Higher Education Malaysia. Adam, F. (2019). What to know about coronary heart disease. Medical News Today, 31 March, 30 - 33. Agata, J., Masuda, A., Takada, M., Higashiura, K., Murakami, H., Miyazaki, Y., & Shimamoto, K. (1997). High plasma immunoreactive leptin level in essential hypertension. American Journal of Hypertension, 10, 1171 – 1174. Al-Azzam, S.I., Alkhateeb, A. M., Alzoubi, K. H., Alzayadeen, R. N., Ababneh, M. A., & Khabour, O. F. (2013). Atorvastatin treatment modulates the interaction between leptin and adiponectin, and the clinical parameters in patients with type II diabetes. Experimental and Therapeutic Medicine, 6, 1565 – 1569. Allison, B. D., Fontaine, K. R., Manson, J. E., Stevens, S., & Vanltallie, T. B. (1999). Annual deaths attributable to obesity in the United States. Journal of the American Medicine, 282(16), 1530 - 1538. Alpert, M. A., & Hashini, M. W. (1993). Obesity and the heart. American Journal of Medicine, 306(2), 117 - 123. Alpert, M. A., Terry, B. E., Cohen, M. V., Fan, T. M., Painter, J. A., & Massey, C. V. (2000). The electrocardiogram in morbid obesity. American Journal of Cardiology, 85(7), 908 - 910. Amador, N., Perez, L. E., & Malacara, J. M. (2004). Leptin and heart sympathetic activity in normotensive obese and non-obese subjects. Italian Heart Journal, 5, 29 - 35. Anna, S., Mariusz, S., Rafal, N. W., Mareh, P., Maciej, B., & Jaceh, R. (2014). Assessment of relationship between lipid parameters and obesity indices in non-diabetic obese patients. Journal of Medical Science Monitor, 20, 2683 – 2688. Austin, M. A., Breslow, J. L., & Hennekens, C. H. (1988). Low-density lipoprotein subclass patterns and risk of myocardial infarction. Journal of the American Medical Association, 260(13), 1917 – 1921. Austin, M. A. (2000). Triglyceride, small dense low-density lipoprotein, and the atherogenic lipoprotein phenotype. Current Atherosclerosis Reports, 2(3), 200 – 207. Bacha, T. E., & Torres, A. G. (2016). Phospholipids: physiology. Encyclopedia of food and health, 352 – 359. Baizurah, M. H., Rashidah, M., Nafishah, A., Noorhayati, A. R., Siti, S. M., Munirah, A. R., & Siti, G. L. (2013). Handbook of Pathology Service 4th edition. Kuala Lumpur: Kementerian Kesihatan Malaysia. Belthowski, J. (2006). Leptin and atherosclerosis. Atherosclerosis, 189, 47 – 60. Benjamin, E. J., Virani, S. S., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., & Matsushita, K. (2018). American Heart Association Council on Epidemiologyand Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics, 137(12), 67 - 492. Bibbin, D. K., & Grossman, D. C. (2017). Folic acid for the prevention of neural tube defects: US Preventive Services Task Force Recommendation Statement. Journal of the American Medical Association, 317(2), 183 – 189. Bodary, P. F., Westtrick, R. J., Wickenheiser, K. J., Shen, Y., & Eitzman D. T. (2002). Effect of leptin on arterial thrombosis following vascular injury in mice. Journal of the American Medical Association, 287(13), 1706 - 1709. Carapetis, J. R., Steer, A. C., Mulholland, E. K., & Weber, M. (2005). The global burden of group A streptococcal disease. Lancet Infectious Disease 5(11), 685-694. Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999). Body mass index and mortality in a prospective cohort of US adults. The New England Journal of Medicine, 341(15), 1097 - 1105. Carlsson, S., Midthjell, K., & Grill, V. (2004). Smoking is associated with an increased risk of type 2 diabetes but a decreased risk of autoimmune diabetes in adults: an 11-year follow-up incidence of diabetes in the Nord-Trendelag study. Diabetologia, 47(11), 1953-1956. Chang, K. T., & Chen, J. Y. (2018). Which obesity index is the best predictor for high cardiovascular disease risk in middle-age and elderly population. Archives of Gerontology and Geriatrics, 78, 165 – 170. Chen, T. H., Lee, C. J., Wang, J. H., & Hsu, B. G. (2018). High serum leptin level is associated with peripheral artery disease in geriatric individuals. International Journal of Gerontology, 12(3), 191 -195. Chiba, T., Shinozaki, S., Nakazawa, T., Kawakami, A., Ai, M., Kaneko, E., Kitagawa, M., Kondo, K., Chait, A., & Shimokado, K. (2008). Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice. Atherosclerosis, 196, 68 – 75. Cohen, B., Novick, D., & Rubinstein, M. (1996). Modulation of insulin activities by leptin. Science, 274, 1185 – 1188. Considine, R. V., & Caro, J. F. (1997). Leptin and regulation of body weight. The International Journal of Biochemistry and Cell Biology, 29(11), 1255 - 1272. Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., & Bauer, T. L. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine, 334(5), 292 - 295. Correia, M. L., & Haynes, W. G. (2004). Leptin, obesity and cardiovascular disease. Current Opinion in Nephrology Hypertension, 13, 215 – 223. Corsonello, A., Perticone, F., Malara, A., Domenico, D., Loddo, S., Buemi, M., Ientile, R., & Corica, F. (2003). Leptin-dependent platelet aggregation in healthy, overweight and obese subjects. International Journal of Obesity and Related Metabolic Disorder, 27, 566 – 573. Courten, M., Zimmet, P., Hodge, A., Collins, V., Nicolson, M., Staten, M., Dowse, G., & Albert, K. G. (1997). Hyperleptinaemia: the missing link in the metabolic syndrome? Diabetic Medicine, 14, 200 – 208. Cui, Y., Blumenthal, R. S., & Flaws, J. A. (2001). Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Archives of Internal Medicine, 161, 1413 – 1419. Degawa, Y. M., Uotani,S., Yamaguchi, Y., Takahashi, R., Abe, T., Kuwahara, H., Yamasaki, H., & Eguchi, K. (2002). Ethanol inhibits leptin-induced STAT3 activation in Huh7 cells. Federation of European Biochemistry Society Letters, 525(1-3), 116 - 120. De, V. P., Saladin, R., Auwerx, J., & Staels, B. (1995). Induction of the ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. Journal of Biological Chemistry, 270(27), 15958 - 15961. Donald, S. F., & Robert, S. G. (1958). Transport of fatty acids. American Journal of Physiology, 38, 585 – 630. Donna, L. L. (2017). Clinical chemistry: Fundamentals and laboratory techniques. St Louis, Missouri: Elsevier Durrington, P., & Soran, H. (2004). Hyperlipidemia. Metabolism of Human Disease, 47(11), 295– 302. Earnest, C. P., Artero, E. G., Sui, X., Lee, D. C., Church, T. S., & Blair, S. N. (2013). Maximal estimated cardiorespiratory fitness, cardiometabolic risk factors, and metabolic syndrome in the aerobics centre longitudinal study. Mayo Clinic Proceeding, 88(3), 259-270. Elosua, R., Molina, L., Fito, M., Arquer, A., Sanchez-Quesada, J. L., Covas, M. L., Ordonez- Llanos, J., & Marrugat, J. (2003). Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women. Atherosclerosis, 167(2), 327-334. Ficek, J., Kokot, F., & Chudek, J. (2002). Influence of antihypertensive treatment with perindopril, pindolol or felodipinon plasma leptin concentration in patients with essential hypertension. Hormone and Metabolic Research, 34, 703 - 708. Fisher, E. A., Feig, J. E., Hewing, B., Hazen, S. L., & Smith, J. D. (2012). High-density Lipoprotien Function, dysfunction, and reverse cholesterol transport. Arteriosclerosis, Thrombosis and Vascular Biology, 32(12), 2813 - 2820. Frank, S., Colliver, J. A., & Frank, A. (1986). The electrocardiogram in obesity: statistical analysis of 1.029 patients. The Journal of the American College of Cardiology, 7(2), 295 - 299. Fogari, R., Derosa, G., & Zoppi, A. (2005). Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients. Hypertension Research, 28, 209 - 214. Ford, T. J., Corcoran, D., & Berry, C. (2018). Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need. Heart, 104, 284 – 292. Fox, K. A. A., Metra, M., & Morais, J. (2020). The myth of stable coronary artery disease. Nature Reviews Cardiology, 17, 9 – 21. Glueck, C. J., Fontaine, R. N., Wang, P., Subbiah, M. T., Weber, K., Illig, E., Streicher, P., Sieve, S. L., Tracy, T. M., Lang, J. E., & McCullough, P. (2001). Metformin reduces weight, centripetal obesity, insulin, leptin, and lowdensity lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism, 50, 856 – 861. Gunnell, D.J., Frankel, S. J., Nanchahal, K., Peters, T. J., & Davey, S. G. (1998) Childhood obesity and adultcardiovascular mortality: a 57-y follow-up study based on the Boyd Orr cohort. The American Journal of Clinical Nutrition, 67(6), 1111-1118. Han, S. H., Quon, M. J., & Koh, K. K. (2007). Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction. Current Opinion in Lipidology, 18, 58 – 65. Harris, R. B., Ramsay, T. G., Smith, S. R., & Bruch, R. C. (1996). Early and late stimulation of ob mRNA expression in meal-fed and overfed rats. Journal of Clinical Investigation, 97(9), 2020 - 2026. Hasty, A. H., Shimano, H., Osuga J., Namatame, I., Takahashi, A., Yahagi, N., Perrey, S., Iizuka, Y., Tamura, Y., Amemiya, K.M., Yoshikawa, T., Okazaki, H., Ohashi, K., Harada, K., Matsuzaka, T., Sone, H., Gotoda , T., Nagai, R., Ishibashi, S., & Yamada, N. (2001). Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low-density lipoprotein receptor. Journal of Biological Chemistry, 276, 37402 – 37408. Hennige, A. M., Stefan, N., Kapp, K., Lehmann, R., Weigert, C., Beck, A., Moeschel, K., Mushack, J., Schleicher, E. & Häring, H. U. (2006). Leptin downregulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1. Journal of Federation American Society for Experimental Biology, 20, 1206 – 1208. Henning, R. J., Johnson, G. T., Coyle, J. P., & Harbonson, R. D. (2017). Acrolein Can Cause Cardiovascular Disease: A Review. Cardiovascular Toxicology, 17(3), 227 - 236. Holcomb, I. N., Kabakoff, R. C., Chan, B., Baker, T. W., Gurney, A., Henzel, W., Nelson, C., Lowman, H. B., Wright, B. D., Skelton, N. J., Frantz, G. D., Tumas, D. B., Peale, F. V., Shelton, D. L., & Hebert, C. C. (2000). FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. Journal of European Molecular Biology Organization, 19(15), 4046 - 4055. Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, H., Sakai, N., Nakajima, T., Hasegawa, K., Muraguchi, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Hanafusa, T., & Matsuzawa, Y. (2000). Plasma concentrations of a novel adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis and Vascular Biology, 20, 1595 - 1599. Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993). Adipose expression of TNF-α: direct role in obesity linked insulin resistance. Science 259(5091), 87 - 91. Howard, B. V., Ruotolo, G., & Robbins, D. C. (2003). Obesity and dyslipidemia. Endocrinology and Metabolism Clinics of North America, 32, 855 – 867. Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983). Obesity as an independents risk factor for cardiovascular diease: a 26-year follow-up of participiants in the Framingham Heart Study. Circulation, 67(5), 968 - 977. Ioana, D., & Mathue, M. B. (2018, May 17). Heart failure. Medscape. Retrieved from http://emedicine.medscape.com/article/163062. Joseph, N. (2017). What to know about Artherosclerosis. Medical News Today, 14 July, pp.42. John, G. C., Catarina, I. K., William, J. R., Eric, D. P., Paul, D. F., William, J. F., Michael, G., Charles, V. P., Joseph, P. O., Robert, J. Z., Jan, P., Alan, J. T., & Philip, G. (2011). Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. Journal of the American Medical Association, 306(19), 2120 – 2127. Judith, M., George, A. M., Shanthi, M., & Kurt, G. (2004). WHO: The Atlas of Heart Disease and Stroke, 48 - 49. Kantor, M. A., Cullinane, E.M., Sady, S.P., Herbert, P.N., & Thompson, P.D. (1987). Exercise acutely increases high density lipoprotein-cholesterol and lipoprotein lipase activity in trained and untrained men. Metabolism 36(2), 188 - 192. Karen, A. M., Lewis, H. K., Kim, S. T., & Chang, Y. F. (2001). Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke, 32(5), 1104 - 1111. Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995). The expression of tumour necrosis factor in human adipose tissu. Regulation by obesity,weight loss, and relationship to lipoprotein lipase. Journal of Clinical Investigation, 95(5), 2111 - 2119. Khera, A. V., Cuchel, M., Llera-Moya M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., Mohler, E. R., Rothblast, G. H., & Rader, D. J. (2011). Cholesterol efflux capacity high-density lipoprotien function, and atherosclerosis. The New England Journal of Medicine, 364(2), 127 -135. Kim, J. A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006). Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation, 113, 1888 – 1904. Koh, K. K. (2000). Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovascular Research, 47, 648 – 657. Kolaczynski, J. W., Nyce, M. R., Considine, R. V.,Boden, G., Nolan, J. J., Henry, R., Mudalir, S. R., Olefsky, J., & Caro, J. F. (1996). Acute and chronic effect of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes, 45(5), 699 -701. Konstantinides, S., Schafer, K., Koschnick, S., & Loskutoff, D. J. (2001). Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrobotic disease in obesity. Journal of Clinical Investigation, 108(10), 1533 -1540. Krysiak, R., Zmuda, W., & Okopien, B. (2014). The effect of simvastatin - ezetimibe combination therapy on adipose tissue hormones and systemic inflammation in patients with isolated hypercholesterolemia. Cardiovascular Therapeutics, 32, 40 – 46. Leroy, P., Dessolin, S., Villageois, P., Moon, B.C., Friedman, J.M., Ailhaud, G., & Dani, C. (1996). Expression of the ob gene in adipose tissue:regulation by insulin. Journal of Biological Chemistry, 271(5), 2365 - 2368. Li, L., Mamputu, J. C., Wiernsperger, N., & Renier, G. (2005). Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. Diabetes, 54, 2227 – 2234. Lonnqvist, F., Nordfors, L., & Schalling, M. (1999). Leptin and its potential role in human obesity. Journal of Internal Medicine, 245(6), 643 - 652. Lundasen, T., Liao, W., Angelin, B., & Rudling, M. (2003). Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7-hydroxylase (Cyp7a1) in leptin deficient (ob/ob) mice. Journal of Biological Chemistry, 278, 43224 – 43228. Madej, T., Boguski, M., & Bryant, S. H. (1995). Threading analysis suggests that the obese gene product (leptin) in white adipose tissue and 3T3-L1 adipocytes. Proceeding of the National Academy of Sciences of the USA, 373(1), 13 - 18. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996). cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose Most abundant gene Transcript 1). Biochemical Biophysical Research Communications, 221(2), 286 - 289. Maeda, T., & Horiuchi, N. (2009). Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation. Journal of Biochemistry, 145, 771 – 781. Maffei, M., Halaas, J., & Ravussin, E. (1995). Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight reduced subjects. Nature Medicine, 1, 1155 - 1161. Maingrette, F., & Renier, G. (2003). Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. Diabetes, 52, 2121 – 2128. Mallamaci, F., Cuzzola, F., Tripepi, G., Cutrupi S., Parlongo, S., Tripepi, R., & Zoccali, C. (2000). Gender-dependent differences in plasma leptin in essential hypertension. American Journal of Hypertension, 13, 914 – 920. Manson, J. E., Willet, W. C., Stampfer, M. J., Colditz, G. A., Hunter, D. J., Hankinson, S. E., Hennekens, C. H., & Speizer, F. E. (1995). Body weight and mortality among women. The New England Journal of Medicine, 333(11), 677 – 685. Marcovinci, S. M., & Morrisett, J. D. (1995). Structure and metabolism of lipoprotein (a). Current Opinian in Lipidology, 6, 136 – 145. Margaret, K. H. (2010). Influence of Age and Health Behaviors on Stroke Risk: Lessons from Longitudinal studie. Journal of the American Geriatrics Society, 58(2), 325-328. Margetic, S., Gazzola, C., Pegg, G. G., & Hill, R. A. (2002). Leptin: a review of its peripheral actions and interactions. International Journal of Obesity and Related Metabolic Disorder, 26, 1407 – 1433. Mastej, M., Jozwiak, J., & Lukas, W. (2006). Assessment and comparison of lipid parameters according to sex and body mass index BMI. Lipidogram 2004. Lipidogram 5 years. Journal of Polish Heart, 64(2), 153 – 160. Masuo, K., Mikami, H., & Ogihara, T. (2001). Weight reduction and pharmacologic treatment in obese hypertensives. American Journal of Hypertension, 14, 530 - 538. Matsuzaka, T., Sone, H., Gotoda, T., Nagai, R., Ishibashi, S., & Yamada, N. (2001). Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. Journal of Biological Chemistry, 276, 37402 – 37408. McTernan, C. L., Harte, A. L., Levick, P. L., Barnett, A. H., & Kumar, S. (2002). Resistin central obesity and type 2 diabetes. Lancet, 359(9300), 46 - 47. Mendis, S., Puska, P., & Norrving, B. (2011). Global atlas on Cardiovascular Disease Prevention and Control. World Health Organization in collaboration with the World Heart Federation and World stroke Organization, 3 - 18. Michael, M. B., William, A. S., & Craig, H. B. (2018) Stable coronary artery disease: treatment. American Academy of Family Physicians, 97(6), 376 – 384. Mohammad, N. K., & Mohamad, K. (2016). Comparative study of serum lipid profile of obese and non-obese students (Male) of Aljouf University. International Journal of Biomedical and Advance Research 7(1), 35 – 37. Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Warenham, N.J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., Cheetham, C. H., Earley, A. R., Barnett, A. H., Prins, J. B., & O’rahilly, S. (1997). Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature, 387(6636), 903 - 908. Mora, S., & Pessin, J. E. (2002). An adipocentric view of signalling and intracellular trafficking. Diabetes Metabolism Research Review, 18(5), 345 - 356. Morris, J.N., Chave, S.P., Adam, C., Sirey, C., Epstein, L., & Sheehan, D.J. (1973). Vigorous exercise in leisure-time and the incidence of coronary heart-diease. Lancet, 301(7799), 333 – 339. Muller, G., Erlt, J., Gerl, M., & Preibisch, G. (1997). Leptin impairs metabolic actions of inulin in isolated rat adiposecytes. Journal of Biological Chemistry, 272(16), 10585 - 10593. Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007). Cardiovascular actions of insulin. Endocrine Reviews, 28, 463 – 491. Muoio, D. M., Dohm, G. L., Fiedorek, F. T., Tapscott, E. B., & Coleman, R. A. (1997). Leptin directly alters lipid partitioning in skeletal muscle. Diabetes, 46, 1360 – 1363. Mushack, J., Schleicher, E., & Häring, H.U. (2006). Leptin downregulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1. Federation of American Societies for Experimental Biology Journal, 20, 1206 – 1208. Myres, G. L., Kimberly, M. M., Waymack, P. P., Smith, S. J., Cooper, G. R., & Sampson, E. J. (2004). A reference method laboratory network for cholestrol: a model for standardization and improvement of clinical laboratory measurements. Clinical Chemistry, 46(11), 1762 - 1772. Nolan, J. J., Olefsky, J. M., Nyce, M. R., Considine, R. V., & Caro, J. F. (1996). Effect of troglitazone on leptin production.Studies in vitro and in human subjects. Diabetes 45(9), 1276 - 1278. Onwuka, E., King, N., Heuer, E., & Breuer, C. (2018). The Heart and Great Vessels. Cold Spring Harbor Perspectives in Medicine, 8(3), 3 - 6. O’Rourke, L., Yeaman, S. J., & Shepherd, P. R. (2001). Insulin and leptin acutely regulate cholesterol ester metabolism in macrophages by novel signalling pathways. Diabetes, 50, 955 – 961. O’Rourke, L., Gronning, L. M., Yeaman, S. J., & Shepherd, P. R. (2002). Glucosedependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin. Journal of Biological Chemistry, 277, 42557 – 42562. Ozata, M., Avcu, F., Durmus, O., Yilmaz, I., Ozdemir, I.C., & Yalcin, A. (2011). Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency. Obesity Research, 9, 627 – 630. Paolo, P. (1999). Hypertension. Journal of American Heart Association, 33(2), 622 - 625. Parhami, F., Tintut, Y., Ballard, A., Fogelman, A.M., & Demer, L. L . (2001). Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circulation Research, 88, 954 – 960. Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collons, F. (1995). Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269(5223), 543 - 546. Piatti, P., Mario C., Monti, L.D., Fragasso, G., Sgura, F., Caumo, A., Setola, E., Lucotti, P., Galluccio, E., Ronchi, C., Origgi, A., Zavaroni, I., Margonato, A., & Colombo, A. (2003). Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation, 108, 2074 – 2081. Piemonti, L., Calori, G., Mercalli, A., Lattuada, G., Monti, P., Garancini, M.P., Costantino, F., Ruotolo, G., Luzi, L., & Perseghin, G. (2003). Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucoseintolerant women: impact on cardiovascular mortality. Diabetes Care, 26, 2883 – 2889. Rainwater,,D. L., Comuzzie, A. G., Vandeberg, J. L., Mahaney, M. C., & Blangero J. (1997). Serum leptin levels are independently correlated with two measures of HDL. Atherosclerosis, 132(2), 237 - 243. Ramachandran, S.V., & Emelia, J.B. (2016). The future of cardiovascular Epidemiology. Circulation, 133(25), 2626 - 2633. Ramaraj, R., & Sorrell, V. L. (2009). Peripartum cardiomyopathy: causes, diagnosis, and treatment. Cleveland Clinic Journal of Medicine, 76(5), 289 - 296. Rea, T. D., Hechbert, S. R., Kaplan, R. C., Psaty, B. M., Smith, N. L., Lemaitre, R. N., & Lin, D. (2001). Body mass index and the risk of recurrent coronary events following acute myocardial infarction. The American Journal of Cardiology, 88(5), 467 - 472. Rexrode, K. M., Carey, V. J., & Hennekens, C. H. (1998). Abdominal obesity and coronary heart disease in women. Journal of the American Medical Association, 280(21), 1843 - 1845. Rich, E. J. W., Manson, J. E., Hennekens, C. H., & Buring, J. E. (1995). The primary prevention of coronary heart disease in women. The New England Journal of Medicine, 332(26), 1758 - 1766. Roffi, M, Patrono, C., Collet, J. P., Christian, M., Marco, V., Felicita, A., Jeroen, J. B., Michael, A. B., Carlos, B., Derek, P. C., Baris, G., Gerd, H., Keld, K., Patrizio, L., Ulf, L., Julinda, M., Debabrata, M., Robert, F. S., & Stephan, W. (2016). 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology(ESC). Europe Heart Journal, 37(3), 267 -315. Rong, S., Liu, M., Lu, L., Zheng, Y., & Zhang, P. (2015) Congenital Heart Disease: cause, diagnosis, symptoms and treatments. Cell Biochemistry and Biophysics, 72(3), 857-860. Roth, G. A, Abate, D., Abate, K. H. Abay, S. M., Abbafati, C., & Abil, O. Z. (2017). A systematic analysis for the Global Burden of Disease Study. Lancet, 392(10159), 1736 - 1788. Sacks, F. M., & Campos, H. (2003). Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal. The Journal of Clinical Endocrinology & Metabolism, 88(10), 4525 – 4532. Saladin, R., De, V. P., Guerre, M.M., Leturque, A., Girard, J., Staels, B., & Auwerx, J. (1995) Transient increases in obese gene expression after food intake or insulin administration. Nature, 377(6549), 527 - 529. Salisbury, G. S., Roche, A. F., Chumlea, W. C., & Siervogel, R. M. (1994). Cardiovascular disease risk factors and body composition: a review. Nutrition Research, 14(2), 1721 - 1727. Sandra, A., Cheryl, S., & Jenny, S. D. (2019a). Introduction to basic cardiac. Dysrhythmias, 5, 1 – 2. Sandra, A., Cheryl, S., & Jenny, S. D. (2019b). Introduction to basic cardiac. Dysrhythmias, 5, 29 - 30. Satoshi, I., Kazuya, M., & Ryutaro, K. (2017). Effect of metformin treatment on blood leptin and ghrelin levels in patients with type 2 diabetes mellitus. Journal of Diabetes, 9, 526 – 535. Schwartz, M. W., Selley, R. J., Campfield, L. A., Burn, P., & Baskin, D. G. (1996). Identification of leptin action in rat hypothalamus. Journal of Clinical Investigagtion, 98(5), 1101 - 1106. Sesso, H. D., Lee, I. M., Gaziano, J.M., Robert, J.G., & Julie, E.B. (2001). Maternal and paternal history of myocardial infraction and risk of cardiovascular disease in men and women. Circulation, 104(4), 393 - 398. Seufert, J. (2004). Leptin effects on pancreatic beta-cell gene expression and function. Diabetes, 53(1), 152 – 158. Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999). Leptin reverse insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature, 401(6784), 73 - 76. Sierra, H. M. R., Nath, A. K., Murakami, C., Garcia, C. G., Papapetropoulos, A., Sessa, W. C., Madge, L. A., Schechner, J. S., Schwabb, M. B., Polverini, P. J., & Flores, R. J. R. (1998). Biological action of leptin as an angiogenic factor. Science, 281(5383), 1683 - 1686. Singhal, A., Farooqi, I. S., Cole, T. J., O’Rahilly, S., Fewtrell, M., Kattenhorn, M., Lucas, A., & Deanfield, J. (2002). Influence of Leptin on Arterial Distensibility: a novel link between obesity and cardiovascular disease? Circulation, 106(15), 1919 - 1924. Sivitz, W. I., Walsh, S. A., Morgan, D. A., Thomas, M. J., & Haynes, W. G. (1997). Effects of leptin on insulin sensitivity in normal rats. Endocrinology, 138, 3395 – 3401. Sjostrom, L. V. (1992). Mortality of severely obese subjects. The American Journal of Clinical Nutrition, 55(2), 516 - 523. Skurk, T., Harmelen, V., & Blum, W.F. (2005). Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway. Obesity Research, 13, 969 - 973. Slieker, L. J., Sloop, K. W., Surface, P. L., Kriauciunas, A., LaQuier, F., Manetta, J., Bue- Valleskey, J., & Stephensa, T.W. (1996). Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. Journal of Biological Chemistry, 271(10), 5301 - 5304. Soderberg, S., Ahren, B., Stegmayr, B., Johnson, O., Wiklund P. G., Weinehall, L., Hallmans, G., & Olsson, T. (1999). Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke, 30, 328 – 337. Soderberg, S., Olsson, T., Eliasson, M., Johnson, O., & Ahrén, B. (1999). Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. Journal of Internal Medicine, 245, 533 – 543. Sonmez, A., Kisa, U., & Uckaya, G. (2001). Effects of losartan treatment on T-cell activities and plasma leptin concentrations in primary hypertension. Journal of the Renin-Angiotensin-Aldosterone System, 2, 112 - 216. Spranger, J., Kroke, A., Mohlig, M., Hoffman, k., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. (2003). Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes, 52(3), 812 - 817. Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001). The hormone resistin links obesity to diabetes. Nature, 409(6818), 307 - 312. Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey, M. C. N., Blum, C. B., & Eckel, R. H. (2014). 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129, 1 – 45. Sugiyama, T., Tsugawa, Y., Tseng, C. H., Kobayashi, Y., & Shapiro, M. F. (2014). Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins? Journal of the American Medical Association, 174, 1038 – 1045. Szotowska, M., Czerwienska, B., Adamczak, M., Chudek, J., & Wiecek, A. (2012). Effect of low-dose atorvastatin on plasma concentrations of adipokines in patients with metabolic syndrome. Kidney Blood Pressure Research, 35, 226 – 232. Tartaglia, L. A., Dembski, M., Weng, X., Deng, N., Culpeper, J., Devos, R., Richards, G. J., Campfield, L. A., Clark, F. T., Deeds, J., Muir, C., Sanker, S., Moriarty, A., Moore, K. J., Smutko, J. S., Mays, G. G., Wool, E. A., Monroe, C. A., & Tepper, R. I. (1995). Identification and expression cloning of a leptin receptor, OB-R. Cell, 83(7), 1263 -1271. Thomas, F. L. (2018). Epidemiology of cardiovascular disease: the new ESC Atlas and beyond. Europe Heart Journal, 39(7), 489 - 492. Thomas, K. M., Panagiotis, N. M., George, A. S., Krespi, P. G., Hatzizacharias, A. N., Kyriaki, D. K., Chronakis, E. V., Anastasiadis, G., Triposkiadis, F. K., & Kyriakidis, M. K. (2003). Elevated Plasma Leptin Levels Pre-exist in Healthy Descendants of Patients with Essential Hypertention. Helleni c Journal of Cardiology, 138(5), 922 - 925. Tim, N. (2009). What to know about Arrhythmia. Medical News Today, 9 Sep, 52 - 54. Timmis, A., Townsend, N., Gale, C., Grobbee, R., Maniadakis, N., Flather, M., Wilkins, E., Wright, L., Vos, R., Bax, J., Blum, M., Pinto, F., & Vardas, P. (2018). Europen Society of Cardiology: Cardiovascular Disease Statistics 2017. European Heart Journal, 39(7), 508 - 579. Tsai, J. P., Wang, J. H., & Chen, M. L. (2017). Association of serum leptin levels with central Arterial stiffness in coronary artery disease patients. BMC Cardiovascular Disorders, 16, pp80. Tuomilehto, J., Elo, J., & Nissmen, A. (1982). Smoking among patients with malignant hypertension. British Medical Journal, 284(1), pp1086. Van, G. L. F., Wauters, M. A., Mertens, I. L., Considine, R. V., & De-Leeuw, I. H. ( 1999). Clinical endocrinology of human leptin. International Journal of Obesity and Related Metavolic Disorders, 23(2), 29 - 36. Varady, K. A., St-Pierre, A. C., Lamarche, B., & Jones P. J. H. (2005). Effect of plant sterols and endurance training on LDL particle size and distribution in previously sedentary hypercholesterolemic adults. European Journal of Clinical Nutrition, 59(1), 518 -525. Wallace, A. M., McMohan, A. D., Packard, C. J., Kelly, A., Shepherd, J., Gaw, A., & Sattar, N. (2001). Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation, 104, 3052 – 3056. Wallaschofski, H., Kobsar, A., Sokolova, O., Siegemund, A., Stepan, H., Faber, R., Eigenthaler, M., & Lohmann, T. (2004). Differences in platelet activation by prolactin and leptin. Hormone and Metabolic Research, 36, 453 – 457. Werner, N., & Nickenig, G. (2004). From fat fighter to risk factor: the zigzag trek of leptin. Arteriosclerosis, Thrombosis and Vascular Biology, 24, 7 – 9. WHO. (2019). Cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. The WHO CVD Chart Working Group 7(10), 1332 - 1345. Willet, W. C., Manson, J. E., Stampfer, M. J., Colditz, G. A., Rosner, B., Speizer, F. E., & Hennekens, C.H. (1995). Weight, changes and coronary heart disease in women. Journal of the American Medical Association, 273(6), 461 - 465. Yaspelkis, B. B., Ansari, L., Ramey, E. L., Holland, G. J., & Loy, S. F. (1999). Chronic leptin Administration increases insulin-stimulated skeletal muscle glucose uptake and transport. Metabolism, 48(5), 671 - 676. Yu, X. H., Fu, Y. C., Zhang, D. W., Kai, Y., & Tang, C. L. (2013). Foam cells in atherosclerosis. Clinica Chimica Acta, 424, 245 – 252. Yvette, B. (2018). Endocarditis: What you need to know. Medical News Today, 22 May, 40 - 42. Zeidan, A., Purdham, D.M., Rajapurohitam, V., Javadov, S., Chakrabarti, S., & Karmazyn, M. (2005). Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1 dependent mechanisms and mediates stretch-induced hypertrophy. Journal of Pharmacology and Experimental Therapeutics, 315, 1075 – 1084. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J.M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature, 372(6505), 425 - 432.

Similar Items